These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8304541)

  • 1. ANF-C-receptor-mediated inhibition of aortic smooth muscle cell proliferation and thymidine kinase activity.
    Cahill PA; Hassid A
    Am J Physiol; 1994 Jan; 266(1 Pt 2):R194-203. PubMed ID: 8304541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clearance receptor-binding atrial natriuretic peptides inhibit mitogenesis and proliferation of rat aortic smooth muscle cells.
    Cahill PA; Hassid A
    Biochem Biophys Res Commun; 1991 Sep; 179(3):1606-13. PubMed ID: 1656960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors.
    Cahill PA; Hassid A
    J Cell Physiol; 1993 Jan; 154(1):28-38. PubMed ID: 7678266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the ANF-C receptor ligand des[Cys105,Cys121]rANF(104-126) on ANF internalization and cGMP production by bovine pulmonary artery endothelial cells.
    Smyth EM; Keenan AK
    Life Sci; 1994; 54(1):1-7. PubMed ID: 8255164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial and C-type natriuretic peptides amplify growth factor activity in primary aortic smooth muscle cells.
    Dhaunsi GS; Hassid A
    Cardiovasc Res; 1996 Jan; 31(1):37-47. PubMed ID: 8849587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype.
    Mimeault M; Fournier A; Féthiere J; De Léan A
    Mol Pharmacol; 1993 May; 43(5):775-82. PubMed ID: 8502232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts.
    Cao L; Gardner DG
    Hypertension; 1995 Feb; 25(2):227-34. PubMed ID: 7843772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of atrial natriuretic factor-induced inhibition of rat mesangial cell mitogenesis.
    Appel RG
    Am J Physiol; 1990 Sep; 259(3 Pt 1):E312-8. PubMed ID: 1698033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
    Rahmutula D; Gardner DG
    Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-type natriuretic peptide inhibits rat mesangial cell proliferation by a phosphorylation-dependent mechanism.
    Segawa K; Minami K; Jimi N; Nakashima Y; Shigematsu A
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):70-6. PubMed ID: 9459575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological receptors mediate anti-proliferative action of atrial natriuretic peptide in cultured mesangial cells.
    Haneda M; Kikkawa R; Koya D; Sakamoto K; Nakanishi S; Matsuda Y; Shigeta Y
    Biochem Biophys Res Commun; 1993 Apr; 192(2):642-8. PubMed ID: 8387284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of atrial and brain natriuretic peptides upon cyclic GMP levels, potassium transport, and receptor binding in rat astrocytes.
    Beaumont K; Tan PK
    J Neurosci Res; 1990 Feb; 25(2):256-62. PubMed ID: 2157033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway.
    Yu SM; Hung LM; Lin CC
    Circulation; 1997 Mar; 95(5):1269-77. PubMed ID: 9054859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct atrial natriuretic factor receptor sites on cultured bovine aortic smooth muscle and endothelial cells.
    Schenk DB; Johnson LK; Schwartz K; Sista H; Scarborough RM; Lewicki JA
    Biochem Biophys Res Commun; 1985 Mar; 127(2):433-42. PubMed ID: 2983720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide inhibits growth of hepatoblastoma (HEP G2) cells by means of activation of clearance receptors.
    Rashed HM; Sun H; Patel TB
    Hepatology; 1993 Apr; 17(4):677-84. PubMed ID: 7682982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptides increase cAMP production in human thyrocytes via the natriuretic peptide clearance receptor (NPR-C).
    Sellitti DF; Perrella G; Doi SQ; Curcio F
    Regul Pept; 2001 Mar; 97(2-3):103-9. PubMed ID: 11164945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential regulation of natriuretic peptide receptor activity in vascular cells.
    Cao L; Zlock DW; Gardner DG
    Hypertension; 1994 Sep; 24(3):329-38. PubMed ID: 8082940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the atrial natriuretic factor-R1C receptor subtype (B-clone) in cultured rat aortic smooth muscle cells.
    Féthière J; Graihle R; De Léan A
    FEBS Lett; 1992 Jun; 305(2):77-80. PubMed ID: 1352262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP.
    Cornwell TL; Arnold E; Boerth NJ; Lincoln TM
    Am J Physiol; 1994 Nov; 267(5 Pt 1):C1405-13. PubMed ID: 7977701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromodulatory effect of the atrial natriuretic factor clearance receptor binding peptide, cANF(4-23)-NH2 in rabbit isolated vasa deferentia.
    Johnson BG; Trachte GJ; Drewett JG
    J Pharmacol Exp Ther; 1991 May; 257(2):720-6. PubMed ID: 1851836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.